 Revance Therapeutics, Inc. NASDAQ:RVNC Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Jessica Serra Head-Investor Relations and ESG Mark Foley Chief Executive Officer Dustin Sjuts President Toby Schilke Chief Financial Officer Conference Call Participants Ken Cacciatore Cowen and Co Seamus Fernandez Guggenheim David Amsellem Piper Sander Annabel Samimy Stifel Balaji Prasad Barclays Vamil Divan Mizuho Securities Douglas Tsao H.C. Wainwright Rohit Bhasin Needham Operator Welcome to the Revance Therapeutics First Quarter 2022 Financial Results and Corporate Update Conference Call. 